Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The 2020 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of
The options have an exercise price of
View original content to download multimedia:https://www.prnewswire.com/news-releases/blueprint-medicines-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301695108.html
SOURCE
Cassie Saitow, 617-909-3127, ir@blueprintmedicines.com; Andrew Law, 617-844-8205, media@blueprintmedicines.com